Petitions for Inter Partes Review by Valeritas

On January 10, 2019, Valeritas, Inc. and Valeritas Holdings, Inc. (“Petitioners”) filed two Petitions to the USPTO’s Patent Trial and Appeal Board (“Board”) related to U.S. Patent No. 6,736,795 (“the ‘795 Patent’): IPR2019-00552 for inter partes review of claims 1-8 and 16-21, and IPR2019-00553 for inter partes review of claims 1, 2, 4-6, and 16-21. The ‘795 Patent is owned by Roche Diabetes Care, Inc. and is drawn to a device for administering an injectable product.

In IPR2019-00552, Petitioners allege that claims 1, 2, 4-7, and 16-21 are anticipated under 35 U.S.C. § 102, and claims 1-8 and 16-21 are obvious under 35 U.S.C. § 103 over various patent documents. In IPR2019-00553, Petitioners allege that claims 1, 2, 4-6, and 16-21 are anticipated under 35 U.S.C. § 102, and claims 1, 2, and 4-6 are obvious under 35 U.S.C. § 103 over various patent documents. The inter partes reviews remain pending at the Board.

By:  April Breyer Menon

View Attachment (PDF)

View Attachment (PDF)